Cancer Therapy

You have full text access to this OnlineOpen article

TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer†

  1. Zhiwei Wang1,
  2. Wen Song2,
  3. Amro Aboukameel2,
  4. Mussop Mohammad2,
  5. Guoping Wang3,
  6. Sanjeev Banerjee1,
  7. Dejuan Kong1,
  8. Shaomeng Wang3,
  9. Fazlul H. Sarkar1,
  10. Ramzi M. Mohammad2,‡,*

Article first published online: 4 JUN 2008

DOI: 10.1002/ijc.23610

Issue

International Journal of Cancer

International Journal of Cancer

Volume 123, Issue 4, pages 958–966, 15 August 2008

Additional Information

How to Cite

Wang, Z., Song, W., Aboukameel, A., Mohammad, M., Wang, G., Banerjee, S., Kong, D., Wang, S., Sarkar, F. H. and Mohammad, R. M. (2008), TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer. Int. J. Cancer, 123: 958–966. doi: 10.1002/ijc.23610

Author Information

  1. 1

    Department of Pathology, Karmanos Cancer Institute, Wayne State University, Detroit, MI

  2. 2

    Department of Internal Medicine, Division of Hematology and Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI

  3. 3

    Department of Internal Medicine, Pharmacology and Medicinal Chemistry, University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI

  1. ‡

    Fax: +313-576-8389.

*Department of Internal Medicine, Karmanos Cancer Institute, Wayne State University School of Medicine, 732 HWCRC, 4100 John R. Street, Detroit, MI 48201

  1. †

    Conflict of Interest: University of Michigan has filed a patent on TW-37, which has been licensed by Ascenta Therapeutics Inc. University of Michigan and Dr. Shaomeng Wang own equity in Ascenta. Dr. Shaomeng Wang also serves as a consultant for Ascenta and is the principal investigator on research contract from Ascenta to University of Michigan.

Publication History

  1. Issue published online: 12 JUN 2008
  2. Article first published online: 4 JUN 2008
  3. Manuscript Accepted: 11 MAR 2008
  4. Manuscript Received: 7 JUL 2007

Funded by

  • National Cancer Institute, NIH. Grant Number: R01CA109389
  • NIH. Grant Number: 5R01CA101870
  • NIH. Grant Number: P30CA22453
  • NIH. Grant Number: U19CA11317
  • Department of Defense Breast Cancer Program. Grant Number: BC0009140

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (788K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Naval Bajwa, Chenzhong Liao, Zaneta Nikolovska-Coleska, Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review, Expert Opinion on Therapeutic Patents, 2012, 22, 1, 37

    CrossRef

  2. 2
    Justus Lieber, Verena Ellerkamp, Julia Wenz, Bettina Kirchner, Steven W. Warmann, Jörg Fuchs, Sorin Armeanu-Ebinger, Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells, Pediatric Surgery International, 2011, 28, 2, 149

    CrossRef

  3. 3
    Hiroki Takahashi, Monica C. Chen, Hung Pham, Eliane Angst, Jonathan C. King, Jenny Park, Ethan Y. Brovman, Hideyuki Ishiguro, Diane M. Harris, Howard A. Reber, Oscar J. Hines, Anna S. Gukovskaya, Vay Liang W. Go, Guido Eibl, Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011, 1813, 8, 1465

    CrossRef

  4. 4
    Ivan Cherh Chiet Low, Jia Kang, Shazib Pervaiz, Bcl-2: A Prime Regulator of Mitochondrial Redox Metabolism in Cancer Cells, Antioxidants & Redox Signaling, 2011, 15, 12, 2975

    CrossRef

  5. 5
    Asfar S Azmi, Zhiwei Wang, Philip A Philip, Ramzi M Mohammad, Fazlul H Sarkar, Emerging Bcl-2 inhibitors for the treatment of cancer, Expert Opinion on Emerging Drugs, 2011, 16, 1, 59

    CrossRef

  6. You have free access to this content6
    Wenjie Song, Kaishan Tao, Haimin Li, Chen Jin, Zhenshun Song, Jun Li, Hai Shi, Xiao Li, Zheng Dang, Kefeng Dou, Bmi-1 is related to proliferation, survival and poor prognosis in pancreatic cancer, Cancer Science, 2010, 101, 7
    Direct Link:
  7. 7
    Benjamin D. Zeitlin, Aaron C. Spalding, Marcia S. Campos, Naoki Ashimori, Zhihong Dong, Shaomeng Wang, Theodore S. Lawrence, Jacques E. Nör, Metronomic Small Molecule Inhibitor of Bcl-2 (TW-37) Is Antiangiogenic and Potentiates the Antitumor Effect of Ionizing Radiation, International Journal of Radiation Oncology*Biology*Physics, 2010, 78, 3, 879

    CrossRef

  8. 8
    Bulbul Pandit, Andrei L. Gartel, New potential anti-cancer agents synergize with bortezomib and ABT-737 against prostate cancer, The Prostate, 2010, 70, 8
    Direct Link:
  9. 9
    Andrea S. Rothmeier, Uta M. Schneiders, Romina M. Wiedmann, Ivan Ischenko, Christiane J. Bruns, Anita Rudy, Stefan Zahler, Angelika M. Vollmar, The marine compound spongistatin 1 targets pancreatic tumor progression and metastasis, International Journal of Cancer, 2010, 127, 5
    Direct Link:
  10. 10
    Andrea G.S. Buggins, Chris J. Pepper, The role of Bcl-2 family proteins in chronic lymphocytic leukaemia, Leukemia Research, 2010, 34, 7, 837

    CrossRef

  11. 11
    Simone Fulda, Apoptosis pathways and their therapeutic exploitation in pancreatic cancer, Journal of Cellular and Molecular Medicine, 2009, 13, 7
    Direct Link:
  12. 12
    Yonghua Zhan, Guangfeng Jia, Daocheng Wu, Yiqing Xu, Liang Xu, Design and Synthesis of a Gossypol Derivative with Improved Antitumor Activities, Archiv der Pharmazie, 2009, 342, 4
    Direct Link:
  13. 13
    Ling Lin, Jia Li, Ya-lan Wang, Xiao Lin, Relationship of PARG with PARP, VEGF and b-FGF in colorectal carcinoma, Chinese Journal of Cancer Research, 2009, 21, 2, 135

    CrossRef

  14. 14
    T Ni Chonghaile, A Letai, Mimicking the BH3 domain to kill cancer cells, Oncogene, 2008, 27, S149

    CrossRef

  15. 15
    Jianming Wang, Baolai Xiao, Jianwei Zheng, Shengquan Zou, The effect of targeted magnetic nanopaticles on hepatoma and the expression of bcl-2/bax protein, Journal of Huazhong University of Science and Technology [Medical Sciences], 2008, 28, 4, 443

    CrossRef

View Full Article (HTML) Get PDF (788K)